Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07194382 |
| Consolidated Lead Sponsor | Avalyn Pharma |
| Therapeutic Condition Cohort | Respiratory and Pulmonary |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 160 participants (ESTIMATED) |
| Registered Start Date | 2026-03-10 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Royal Prince Alfred Hospital | Camperdown, Australia | Open Hospital Dossier -> |
| Austin Health | Heidelberg, Australia | Open Hospital Dossier -> |
| The Alfred Hospital | Melbourne, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.